News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Giuseppe Procopio: Results of the prospective multicenter Cassiope trial in renal cell carcinoma
urologysingapore.com
Dec 12, 2024, 09:43

Giuseppe Procopio: Results of the prospective multicenter Cassiope trial in renal cell carcinoma

Giuseppe Procopio, Director of the Genitourinary cancer Unit at National Cancer Institute Foundation, shared on X:

“Happy to share the results of the prospective multicenter Cassiope trial in mRCC.”

A prospective noninterventional real-world study of cabozantinib in pretreated patients with advanced renal cell carcinoma refractory to vascular endothelial growth factor-targeted therapy (CASSIOPE).

Authors: Michael Staehler, Umberto Basso, Jean-Christophe Eymard, Philippe Barthelemy, Pierre Bigot, Mathieu Laramas, Michael Rink, Cristina Suarez, Aline Guillot, Jens Bedke, Paul Hamberg, Rocco De Vivo, Pablo Gajate, Martín Lázaro-Quintela, Priti Rastogi, Valérie Perrot, Bryan Qvick, Pascale Dutailly, Elena Verzoni, Giuseppe Procopio

Giuseppe Procopio

Aline Guillot Bryan Qvick cancer Cassiope trial Cristina Suárez Elena Verzoni Giuseppe Procopio Jean-Christophe Eymard Jens Bedke Martín Lázaro-Quintela Mathieu Laramas Michael Rink Michael Staehler mRCC OncoDaily Oncology Pablo Gajate Pascale Dutailly Paul Hamberg Philippe Barthélémy Pierre Bigot Priti Rastogi renal cell carcinoma Rocco De Vivo Umberto Basso Valérie Perrot
Special Coverage
Blog
Jan 11, 2025, 21:25
Petros Grivas: My heart goes to people in the areas affected by the LA fires
Science
Jan 11, 2025, 21:15
Senthil Kumar: Comprehensive Overview of First-Line Treatment for Metastatic Esophageal Cancer
Blog
Jan 11, 2025, 21:13
Sachin Jain: SCAN Group is committed to supporting each of you during this difficult time
Insight
Jan 11, 2025, 21:11
Adding Blinatumomab to Standard Treatment for Pediatric B-cell ALL
Blog
Jan 11, 2025, 21:09
Lisa Lacasse: ACS CAN's virtual screening of 'Trans Dudes with Lady Cancer'
Science
Jan 11, 2025, 17:09
Biomarker testing in lung cancer: from bench to bedside
Insight
Jan 11, 2025, 16:54
Patrick Forde: Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Blog
Jan 11, 2025, 16:43
Dani Ally Ngayonga is a new member of Cancer Fight Tanzania
Blog
Jan 11, 2025, 16:33
Registration is open for the 8th Annual Meeting of the IACH
Blog
Jan 11, 2025, 16:23
Monica Bertagnolli: Could Engineered Immune Cells Be Used to Treat People with Autoimmune Diseases and Organ Transplants
Insight
Jan 11, 2025, 16:20
Yan Leyfman: iPSC-derived CAR-NK cell therapy with three antitumor modalities
Blog
Jan 11, 2025, 16:15
Roupen Odabashian: The third lesson on using AI for learning